GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biolife Sciences Inc (OTCPK:BLFE) » Definitions » Total Equity

Biolife Sciences (Biolife Sciences) Total Equity : $-0.42 Mil (As of May. 2008)


View and export this data going back to 2005. Start your Free Trial

What is Biolife Sciences Total Equity?

Biolife Sciences's total equity for the quarter that ended in May. 2008 was $-0.42 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Biolife Sciences Total Equity Historical Data

The historical data trend for Biolife Sciences's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biolife Sciences Total Equity Chart

Biolife Sciences Annual Data
Trend Nov04 Nov05 Nov06 Nov07
Total Equity
0.07 0.25 0.25 0.06

Biolife Sciences Quarterly Data
Nov04 Feb05 May05 Aug05 Nov05 Feb06 May06 Aug06 Nov06 Feb07 May07 Aug07 Nov07 Feb08 May08
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.21 0.22 0.06 -0.20 -0.42

Biolife Sciences Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Biolife Sciences's Total Equity for the fiscal year that ended in Nov. 2007 is calculated as

Total Equity=Total Assets(Q: Nov. 2007 )-Total Liabilities(Q: Nov. 2007 )
=3.762-3.702
=0.06

Biolife Sciences's Total Equity for the quarter that ended in May. 2008 is calculated as

Total Equity=Total Assets(Q: May. 2008 )-Total Liabilities(Q: May. 2008 )
=3.041-3.46
=-0.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biolife Sciences Total Equity Related Terms

Thank you for viewing the detailed overview of Biolife Sciences's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Biolife Sciences (Biolife Sciences) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biolife Sciences Inc (OTCPK:BLFE) » Definitions » Total Equity
Comparable Companies
WAR:ERS TWER TSXV:VMY.H BOM:538674 FULO WAR:ECL ASX:REF TSXV:ECT XSAT:CHAL B WAR:AIT NSE:ACCORD WAR:TLG XCNQ:RVR DTGI OSTO:WIFOG WAR:U2K BOM:511116 ASX:ZIP JSE:TLM WAR:SFN
Traded in Other Exchanges
N/A
Address
2831 Street Rose Parkway, No. 200, Henderson, NV, USA, 89052
Website
https://www.biolifesciences.com
Biolife Sciences Inc is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors. The company's technologies include antimicrobial copper air filters and copper-infused textiles. Its revenues are primarily generated from the sale of sanitation products.
Executives
Arthur Viola director, 10 percent owner, officer: CEO

Biolife Sciences (Biolife Sciences) Headlines

From GuruFocus

Rhino Novi Announces Name Change and New CEO

By Marketwired Marketwired • 09-15-2020